(Q39679811)

13 September 2017

title

Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu (English)

1 reference

13 September 2017

0 references

0 references

mesenchymal stem cell

1 reference

Yanique Rattigan

1 reference

13 September 2017

Jing-Mei Hsu

1 reference

13 September 2017

Pravin J Mishra

1 reference

13 September 2017

John Glod

1 reference

13 September 2017

Debabrata Banerjee

1 reference

13 September 2017

language of work or name

English

0 references

publication date

13 July 2010

1 reference

Experimental Cell Research

13 September 2017

published in

1 reference

13 September 2017

volume

316

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

3417-3424

1 reference

13 September 2017

cites work

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Multilineage potential of adult human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Angiogenesis in cancer and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

The tumor microenvironment and metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Molecular responses to hypoxia in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Regulation of angiogenesis by hypoxia: role of the HIF system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Molecular Mechanisms of Tumor Invasion and Metastasis: An Integrated View

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Hypoxia, gene expression, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Microenvironment-induced cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Hypoxia-driven selection of the metastatic phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Putting tumours in context

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

The influence of the microenvironment on the malignant phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Tumor microenvironmental physiology and its implications for radiation oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

The hypoxic tumour microenvironment and metastatic progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Tumor hypoxia and cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Drug resistance and the solid tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Interleukin-6: from basic science to medicine--40 years in immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

IL-6 involvement in epithelial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Optimizing therapeutic strategies to inhibit circulating soluble target molecules with monoclonal antibodies: example of the soluble IL-6 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

Cytokine-binding proteins: stimulating antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

10.1016/J.YEXCR.2010.07.002

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference